Mr. Sylwester Cacek



Mrs. Dorota Cacek



October 02, 2008 17:00 ET

Mr. Sylwester Cacek and Mrs. Dorota Cacek Acquire Units of Helix BioPharma Corp. for Investment Purposes

TORONTO, ONTARIO--(Marketwire - Oct. 2, 2008) - Mr. Sylwester Cacek and Mrs. Dorota Cacek (the "Caceks") announced today that they have jointly acquired 5,300,000 Units in Helix BioPharma Corp. ("Helix"), at a price of $1.68 CAD per Unit (the "Purchase Price") pursuant to a private placement. Each Unit consists of 1 Common share and 0.5 Series "F" Warrants. Each whole Series "F" Warrant entitles the holder to purchase, subject to adjustment, one Common Share of the Corporation at a price $2.36 per share until October 1, 2011. As a result of the acquisition, the Caceks now hold 7,060,000 Common Shares of Helix representing approximately 13.28% of the outstanding common shares of Helix, and 2,650,000 Series "F" Warrants of Helix that, if exercised, would result in the Caceks holding approximately 17.394% of the total outstanding common shares of Helix.

The Caceks acquired these Units for investment purposes and may, from time to time, acquire additional securities of Helix or dispose of such securities as they may deem appropriate.

The Caceks reside at Grubenstrasse 19, 6315 Oberaegeri, Switzerland.

Contact Information

  • Dale & Lessmann LLP
    Mr. David Clark
    Agent of the Caceks in Canada
    (416) 369-7808